Q1 2024 13F Holders as of 31 Mar 2024
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
237M
-
Number of holders
-
212
-
Total 13F shares, excl. options
-
174M
-
Shares change
-
+5.02M
-
Total reported value, excl. options
-
$1.15B
-
Value change
-
+$38.7M
-
Put/Call ratio
-
0.15
-
Number of buys
-
134
-
Number of sells
-
-70
-
Price
-
$6.60
Significant Holders of ADMA BIOLOGICS, INC. - COMMON STOCK (ADMA) as of Q1 2024
233 filings reported holding ADMA - ADMA BIOLOGICS, INC. - COMMON STOCK as of Q1 2024.
ADMA BIOLOGICS, INC. - COMMON STOCK (ADMA) has 212 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 174M shares
of 237M outstanding shares and own 73.66% of the company stock.
Largest 10 shareholders include BlackRock Inc. (18.2M shares), VANGUARD GROUP INC (12.7M shares), STATE STREET CORP (10.6M shares), Nuveen Asset Management, LLC (10.5M shares), Invesco Ltd. (7.8M shares), AMERICAN CENTURY COMPANIES INC (7.13M shares), PERCEPTIVE ADVISORS LLC (6.43M shares), AWM Investment Company, Inc. (5.71M shares), D. E. Shaw & Co., Inc. (5.38M shares), and GEODE CAPITAL MANAGEMENT, LLC (4.81M shares).
This table shows the top 212 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.